Ultralife Corporation (ULBI)
NASDAQ: ULBI · Real-Time Price · USD
15.68
-0.01 (-0.06%)
Nov 20, 2026, 10:25 AM EST - Market open
Ultralife Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 192.14 | 191.16 | 164.46 | 158.64 | 131.84 | 98.27 | |
Revenue Growth | 3.01% | 16.24% | 3.66% | 20.33% | 34.16% | -8.77% |
Cost of Revenue | 142.82 | 145.14 | 122.14 | 119.44 | 102.44 | 73.5 |
Gross Profit | 49.33 | 46.02 | 42.31 | 39.2 | 29.4 | 24.76 |
Selling, General & Admin | 25.95 | 27.04 | 22.72 | 22.19 | 22.19 | 17.43 |
Research & Development | 12.2 | 10.4 | 8.27 | 7.53 | 7.08 | 6.83 |
Operating Expenses | 38.15 | 37.44 | 30.99 | 29.73 | 29.27 | 24.25 |
Operating Income | 11.18 | 8.58 | 11.33 | 9.48 | 0.13 | 0.51 |
Interest Expense | -3.57 | -3.95 | -1.94 | -2.02 | -0.95 | -0.24 |
Currency Exchange Gain (Loss) | - | - | - | 0.11 | 0.38 | 0.06 |
Other Non Operating Income (Expenses) | 2.63 | 1.46 | 0.28 | - | - | - |
EBT Excluding Unusual Items | 10.24 | 6.08 | 9.66 | 7.57 | -0.45 | 0.32 |
Merger & Restructuring Charges | -2.3 | -2.3 | -1.36 | - | - | -0.48 |
Asset Writedown | -12.18 | -12.18 | - | - | - | - |
Other Unusual Items | -0.9 | - | - | 1.54 | - | - |
Pretax Income | -5.14 | -8.4 | 8.3 | 9.12 | -0.45 | -0.15 |
Income Tax Expense | -2.12 | -2.45 | 1.89 | 1.95 | -0.33 | 0.08 |
Earnings From Continuing Operations | -3.02 | -5.95 | 6.41 | 7.17 | -0.12 | -0.23 |
Minority Interest in Earnings | 0.06 | 0.05 | -0.1 | 0.03 | 0 | -0 |
Net Income | -2.96 | -5.9 | 6.31 | 7.2 | -0.12 | -0.23 |
Net Income to Common | -2.96 | -5.9 | 6.31 | 7.2 | -0.12 | -0.23 |
Net Income Growth | - | - | -12.30% | - | - | - |
Shares Outstanding (Basic) | 17 | 17 | 17 | 16 | 16 | 16 |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 16 | 16 | 16 |
Shares Change | -0.46% | -0.74% | 3.33% | 0.63% | 0.55% | -0.37% |
EPS (Basic) | -0.18 | -0.35 | 0.38 | 0.44 | -0.01 | -0.01 |
EPS (Diluted) | -0.18 | -0.35 | 0.38 | 0.44 | -0.01 | -0.01 |
EPS Growth | - | - | -13.64% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.69 | 7.12 | 14.7 | -0.62 | -2.94 | 1.51 |
Free Cash Flow Per Share | -0.04 | 0.43 | 0.88 | -0.04 | -0.18 | 0.09 |
Gross Margin | 25.67% | 24.07% | 25.73% | 24.71% | 22.30% | 25.20% |
Operating Margin | 5.82% | 4.49% | 6.89% | 5.97% | 0.10% | 0.52% |
Profit Margin | -1.54% | -3.08% | 3.84% | 4.54% | -0.09% | -0.24% |
Free Cash Flow Margin | -0.36% | 3.72% | 8.94% | -0.39% | -2.23% | 1.54% |
EBITDA | 16.5 | 14.08 | 15.48 | 13.39 | 4.59 | 4.05 |
EBITDA Margin | 8.59% | 7.36% | 9.41% | 8.44% | 3.48% | 4.12% |
D&A For EBITDA | 5.32 | 5.5 | 4.16 | 3.91 | 4.46 | 3.54 |
EBIT | 11.18 | 8.58 | 11.33 | 9.48 | 0.13 | 0.51 |
EBIT Margin | 5.82% | 4.49% | 6.89% | 5.97% | 0.10% | 0.52% |
Effective Tax Rate | - | - | 22.79% | 21.40% | - | - |